Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by:
Washington Neuropsychology Research Group
ClinicalTrials.gov Identifier:
NCT00914758
First received: June 3, 2009
Last updated: June 4, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)